Yüklüyor......
Bioengineering hemophilia A–specific microvascular grafts for delivery of full-length factor VIII into the bloodstream
Hemophilia A (HA) is a bleeding disorder caused by mutations in the F8 gene encoding coagulation factor VIII (FVIII). Current treatments are based on regular infusions of FVIII concentrates throughout a patient’s life. Alternatively, viral gene therapies that directly deliver F8 in vivo have shown p...
Kaydedildi:
| Yayımlandı: | Blood Adv |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6929393/ https://ncbi.nlm.nih.gov/pubmed/31851760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000848 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|